Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis

Clinical trial NCT02337205 · COMPLETED

Trial details

NCT number: NCT02337205
Sponsor: Athenex, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2014-12-01
Primary completion: 2016-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.